ELV β€” ELEVANCE HEALTH INC

Ownership history in Bridgefront Capital, LLC  Β·  4 quarters on record

This page tracks every 13F SEC filing in which Bridgefront Capital, LLC reported a position in ELEVANCE HEALTH INC (ELV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.41% (2023 Q2)
πŸ“Š Avg. % of fund
0.26%
πŸ“… First filed
2023 Q1
πŸ“… Last filed
2025 Q3
⏱ Quarters held
4

Position Intelligence

Bridgefront Capital, LLC Γ— ELV AI Analytics

πŸ“‰ Bridgefront Capital, LLC underperformed the S&P 500 by –105.0% annually on this ELV position. Timing score: 67% (2/3 decisions correct). Average cost basis: $384.64. Maximum drawdown during holding period: –36.7%.

πŸ“ˆ Position Alpha vs SPY
-105.0%
annualised excess return

❌ Significantly underperformed the S&P 500 by 105.0% ann.
3 quarters analyzed

⏱️ Timing Score
67%

βœ… Decent timing β€” more right than wrong on entries and exits.
2 of 3 add/trim decisions correct

πŸ’° Entry Quality
$384.64
-16.9% vs current ($319.49)

Best entry: $319.49 (2025 Q3)  Β·  Worst: $438.14 (2023 Q1)

πŸ›‘οΈ Drawdown Resilience
–36.7%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
75%
buy-side decisions

3 adds Β· 1 trim. Bought during 2 of 2 down-price quarters. πŸ‚ Consistently bullish β€” fund kept accumulating this position.

πŸ“‘ Position Trajectory
↓ Shrinking
last 4–5 quarters trend

πŸ“‰ Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 0.18% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    ELV price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 4 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 1,905 +1,273 +201.4% 0.18% $616K $319.49
2024 Q3 REDUCED 632 -1,070 -62.9% 0.13% $329K $504.94
2023 Q2 ADDED 1,702 +606 +55.3% 0.41% $756K $424.72
2023 Q1 INITIATED 1,096 β€” β€” 0.31% $504K $438.14
← Back to Bridgefront Capital, LLC Holdings